These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 17587451)

  • 1. Endostatin gene variation and protein levels in breast cancer susceptibility and severity.
    Balasubramanian SP; Cross SS; Globe J; Cox A; Brown NJ; Reed MW
    BMC Cancer; 2007 Jun; 7():107. PubMed ID: 17587451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HRAS1 variable number of tandem repeats and risk of breast cancer.
    Tamimi RM; Hankinson SE; Ding S; Gagalang V; Larson GP; Spiegelman D; Colditz GA; Krontiris TG; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1528-30. PubMed ID: 14693748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high risk of occurrence of sporadic breast cancer in individuals with the 104NN polymorphism of the COL18A1 gene.
    Lourenço GJ; Cardoso-Filho C; Gonçales NS; Shinzato JY; Zeferino LC; Nascimento H; Costa FF; Gurgel MS; Lima CS
    Breast Cancer Res Treat; 2006 Dec; 100(3):335-8. PubMed ID: 16807676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of tumour necrosis factor gene polymorphisms (-308 and -238) in breast cancer susceptibility and severity.
    Azmy IA; Balasubramanian SP; Wilson AG; Stephenson TJ; Cox A; Brown NJ; Reed MW
    Breast Cancer Res; 2004; 6(4):R395-400. PubMed ID: 15217507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor susceptibility and prognosis of breast cancer associated with the G870A polymorphism of CCND1.
    Yu CP; Yu JC; Sun CA; Tzao C; Ho JY; Yen AM
    Breast Cancer Res Treat; 2008 Jan; 107(1):95-102. PubMed ID: 18043898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival.
    Tommiska J; Eerola H; Heinonen M; Salonen L; Kaare M; Tallila J; Ristimäki A; von Smitten K; Aittomäki K; Heikkilä P; Blomqvist C; Nevanlinna H
    Clin Cancer Res; 2005 Jul; 11(14):5098-103. PubMed ID: 16033823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The C1772T genetic polymorphism in human HIF-1alpha gene associates with expression of HIF-1alpha protein in breast cancer.
    Kim HO; Jo YH; Lee J; Lee SS; Yoon KS
    Oncol Rep; 2008 Nov; 20(5):1181-7. PubMed ID: 18949419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum levels of hepatocyte growth factor in patients with breast cancer.
    Sheen-Chen SM; Liu YW; Eng HL; Chou FF
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):715-7. PubMed ID: 15767355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in TP53 and risk of breast cancer in a population-based case control study.
    Sprague BL; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Hampton JM; Chanock SJ; Haines JL; Egan KM
    Carcinogenesis; 2007 Aug; 28(8):1680-6. PubMed ID: 17449902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic variation in pro-inflammatory cytokines (interleukin-1beta, interleukin-1alpha and interleukin-6) associated with the aggressive forms, survival, and relapse prediction of breast carcinoma.
    Snoussi K; Strosberg AD; Bouaouina N; Ben Ahmed S; Chouchane L
    Eur Cytokine Netw; 2005 Dec; 16(4):253-60. PubMed ID: 16464738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
    Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
    Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
    Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum endostatin levels in patients with lung carcinoma.
    Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
    Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients.
    Parr C; Gan CH; Watkins G; Jiang WG
    Angiogenesis; 2006; 9(2):73-81. PubMed ID: 16758268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p27kip1 in breast cancer and its prognostic significance.
    Barnes A; Pinder SE; Bell JA; Paish EC; Wencyk PM; Robertson JF; Elston CW; Ellis IO
    J Pathol; 2003 Nov; 201(3):451-9. PubMed ID: 14595757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer and cyclin D1 gene polymorphism in Turkish women.
    Yaylim-Eraltan I; Ergen A; Görmüs U; Arikan S; Küçücük S; Sahin O; Yigit N; Yildiz Y; Isbir T
    In Vivo; 2009; 23(5):767-72. PubMed ID: 19779113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.